Central venous catheter‐related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Safety of factor VIII inhibitor bypass activity (FEIBA®): 10‐year compilation of thrombotic adverse events
2002 • 218 citations
Thrombogenicity associated with factor IX complex concentrates.
1991 • 154 citations
Safety and Efficacy of Thrombolytic Therapy for Superior Vena Cava Syndrome
1991 • 134 citations
Guidelines for antithrombotic therapy in pediatric patients
1998 • 119 citations
Catheter-related deep venous thrombosis in children with hemophilia
2001 • 111 citations
Induced immunotolerance in factor VIII inhibitor patients.
1984 • 105 citations
Recombinant factor VIIa (NovoSeven®) and the safety of treatment
2001 • 104 citations
Port‐A‐Cath usage in children with haemophilia: experience of 53 cases
1998 • 88 citations
Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with Factor VIII deficiency and a factor VIII inhibitor
1988 • 81 citations
Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors
1999 • 77 citations
The use of central venous catheters (portacaths) in children with Haemophilia
2000 • 66 citations
Prothrombin Concentrates in Treatment of Christmas Disease and Allied Disorders
1969 • 57 citations
The Use of Implantable Venous Access Devices (IVADs) in Children with Hemophilia
1997 • 53 citations
Antihemophilic factor inhibitors. Management with prothrombin complex concentrates
1976 • 53 citations
Fatal Myocardial Infarction Following Therapy with Prothrombin Complex Concentrates in a Young Man with Hemophilia A
1984 • 50 citations
Central venous catheter‐associated thrombosis in severe haemophilia
1999 • 47 citations
Thrombolytic therapy for catheter-related thrombosis
1993 • 45 citations
Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid
1981 • 42 citations
Antihemophilic Factor Inhibitors
1976 • 36 citations
Contrast venography in young Haemophiliacs with implantable central venous access devices
1998 • 34 citations
Use of Prothrombin Complex Concentrates in Hemophiliacs with Inhibitors: Clinical and Laboratory Studies
1978 • 32 citations
Prediction and management of adverse events associated with the use of factor IX complex concentrates.
1993 • 29 citations
Prothrombin Complex Concentrates
1978 • 26 citations
Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate‐related myocardial infarction in patients with haemophilia and inhibitors
2000 • 24 citations
Management of Patients With Factor VIII or IX Inhibitors
2008 • 22 citations
Successful treatment of prolonged superior vena cava syndrome with thrombolytic therapy: A case report
1994 • 16 citations